Skip to content

Mohammad Khader Kamal, M.D.

NPI 1699975755ActiveIndividual· Internal Medicine, Medical Oncology· Ocala, FL

Internal Medicine, Medical Oncology (M.D.) in Ocala, Florida, licensed in FL, with an NPI issued in July 2007. Enrolled in Medicare as practitioner - hematology/oncology. Alnylam Pharmaceuticals Inc. reported $49.31 in payments in 2025, mostly food and beverage.

Overview

NPI1699975755
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedJul 18, 2007
Last updated in NPPESAug 9, 2022
Certified by providerAug 9, 2022

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Medical Oncology Primary207RX0202XME46963FL

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Hematology/Oncology (FL)

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$49.31 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Alnylam Pharmaceuticals Inc.$49.311

What the 2025 payments were for

  • Food and Beverage$49.31 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Medical Oncology providers in Ocala

All Internal Medicine, Medical Oncology providers in Florida →